Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alexander Vlaar and Sanne de Bruin.
Alexander Vlaar
Connection Strength
0.807
Sanne de Bruin
  1. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine. 2021 May; 67:103378.
    View in: PubMed
    Score: 0.236
  2. Efficacy matters: broadening complement inhibition in COVID-19 - Authors' reply. Lancet Rheumatol. 2021 Feb; 3(2):e95-e96.
    View in: PubMed
    Score: 0.230
  3. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
    View in: PubMed
    Score: 0.226
  4. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science. 2021 02 26; 371(6532).
    View in: PubMed
    Score: 0.058
  5. Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19. J Immunol. 2020 12 15; 205(12):3491-3499.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.